Products Zanamivir is commercially available as a dischaler for powder inhalation (Relenza). It has been approved in many countries since 1999. Zanamivir is far less well known than oseltamivir (Tamiflu), probably mainly because of its more complicated administration. Structure and properties Zanamivir (C12H20N4O7, Mr = 332.3 g/mol) exists as a white powder. It has a … Zanamivir
Products Oseltamivir is commercially available as capsules and as a powder for oral suspension (Tamiflu). It has been approved in many countries since 1999. Generics were first registered in the EU in 2014 (ebilfumin) and in many countries in 2018. Structure and properties Oseltamivir (C16H28N2O4, Mr = 312.4 g/mol) is present in drugs as oseltamivir … Oseltamivir
Products Peramivir was approved in the United States in 2014 and in the EU in 2018 as a concentrate for the preparation of an infusion solution (U.S.: Rapivab, EU: Alpivab). It has not yet been registered in many countries. Structure and properties Peramivir (C15H28N4O4, Mr = 328.4 g/mol) is present in the drug as peramivir … Peramivir
Products Laninamivir has been approved in Japan as a powder inhaler since 2010 (Inavir). Structure and properties Laninamivir (C13H22N4O7, Mr = 346,340 g/mol) is present in the drug as laninamiviroctanoate, an octanoyl ester prodrug that is metabolized to the active ingredient laninamivir after application. Effects Laninamivir has antiviral properties against influenza viruses. The effects are … Laninamivir
